This week, AmSpa CEO, Alex R. Thiersch, JD, speaks with Patrick O’Brien, JD, of AmSpa and ByrdAdatto, to discuss the legal concerns with compounded semaglutide and its name-brand drugs. They talk about the basic legal implications of Ozempic and recent lawsuits, compounding pharmacy issues and general guidelines for navigating this area of the law. Their conversation includes:
Read more about the ongoing lawsuits filed by Novo Nordisk, maker of Ozempic and Wegovy, at the AmSpa Now blog. Stay tuned for new updates on the subject as more info becomes available.
This episode of Medical Spa Insider is sponsored by RepeatMD. Visit https://www.repeatmd.com/ to learn more!
Following Your Own Medical Spa Blueprint
Embracing Change in Aesthetic Surgery
Membership Spotlight: La-Tasha Walker
On the Mend: Healing Veterans Physically and Mentally
The Entrepreneur Innovating Sanitation
Protecting Yourself With Insurance Coverage
Member Spotlight: Jill Hawkins, Donaldson Plastic Surgery & Aesthetic Solutions
Connecting Models to Medical Spas
Taking Aesthetics on the Road
Greatest Hits: Medical Spa Ownership - Investing, Expanding and Exiting
Member Spotlight: Cameron Moskos, PA-C
Partnerships That Better Business, Part 2
Creating Genuine Relationships and Increased Revenue
Diversity in Aesthetics: Starting the Conversation
A Look at the Future of Medical Aesthetics
Partnerships that Better Business, Part 1
Member Spotlight: Courtney Anderson
A Pathologist’s Perspective: Finding Success in Medical Spas
Member Spotlight: Amanda Satterwhite, MD
Enhancing Your Listening Skills to Transform Your Business
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Organic Marketing Simplified: Master podcast marketing, fuel podcast growth, and make money podcasting!
THE GO BIZ GUY
The Sigma Femme Podcast
The Prof G Pod with Scott Galloway
The Money Mondays